Drug intelligence / Profile preview

Procosa

Development stage: Unknown
Lead developer: USANA Health Sciences
Modality: Small Molecules
Administration: Oral

Overview

Procosa is a multi-ingredient dietary supplement developed and manufactured by USANA Health Sciences to support joint health, function, and mobility. It features the proprietary InCelligence Joint-Support Complex, which combines glucosamine hydrochloride with Meriva bioavailable curcumin. The formulation also includes vitamin C (as calcium ascorbate), magnesium, and manganese. Procosa is designed to support healthy cartilage maintenance, collagen production, and provide antioxidant activity to protect joint tissues. It is marketed as a nutritional supplement rather than a pharmaceutical drug and is typically administered as three tablets daily.

Brand names: Procosa
Other names: Procosa with InCelligence

Targets

NF-κBPHD1 (Prolyl hydroxylase domain-containing protein 1)

Beyond the preview

Go deeper on Procosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Procosa.

Explore the full profile